138 related articles for article (PubMed ID: 23635997)
41. Changes in plasma erythropoietin and interleukin-6 concentrations in patients with septic shock after hemoperfusion with polymyxin B-immobilized fiber.
Nakamura T; Ebihara I; Shimada N; Koide H
Intensive Care Med; 1998 Dec; 24(12):1272-6. PubMed ID: 9885879
[TBL] [Abstract][Full Text] [Related]
42. Removal of increased circulating CD4+CD25+Foxp3+ regulatory T cells in patients with septic shock using hemoperfusion with polymyxin B-immobilized fibers.
Ono S; Kimura A; Hiraki S; Takahata R; Tsujimoto H; Kinoshita M; Miyazaki H; Yamamoto J; Hase K; Saitoh D
Surgery; 2013 Feb; 153(2):262-71. PubMed ID: 22884251
[TBL] [Abstract][Full Text] [Related]
43. Suppression of high-mobility group box-1 and receptor for advanced glycation end-product axis by polymyxin B-immobilized fiber hemoperfusion in septic shock patients.
Nakamura T; Sato E; Fujiwara N; Kawagoe Y; Maeda S; Yamagishi S
J Crit Care; 2011 Dec; 26(6):546-9. PubMed ID: 21273029
[TBL] [Abstract][Full Text] [Related]
44. [Clinical experiences of endotoxin removal columns in septic shock due to urosepsis: report of three cases].
Yuasa J; Naya Y; Tanaka M; Amakasu M; Yamaguchi K
Hinyokika Kiyo; 2000 Nov; 46(11):819-22. PubMed ID: 11193305
[TBL] [Abstract][Full Text] [Related]
45. Effect over time of endotoxin adsorption therapy in sepsis.
Ueno T; Sugino M; Nemoto H; Shoji H; Kakita A; Watanabe M
Ther Apher Dial; 2005 Apr; 9(2):128-36. PubMed ID: 15828924
[TBL] [Abstract][Full Text] [Related]
46. Polymyxin B-immobilized fiber hemoperfusion with low priming volume in an elderly septic shock patient with marked endotoxemia.
Nakamura T; Kawagoe Y; Ueda Y; Koide H
ASAIO J; 2005; 51(4):482-4. PubMed ID: 16156319
[TBL] [Abstract][Full Text] [Related]
47. Early initiation of polymyxin B-immobilized fiber therapy effective for septic shock after aortic replacement.
Murakami M; Miyauchi Y; Nishida M; Okada H; Hamano K
Ann Thorac Cardiovasc Surg; 2007 Aug; 13(4):287-9. PubMed ID: 17717510
[TBL] [Abstract][Full Text] [Related]
48. Hemoperfusion treatment in a septic shock patient with autosomal dominant polycystic kidney disease and increased HMGB1 protein levels.
Nakamura T; Kawagoe Y; Ueda Y; Yamada S; Koide H
Blood Purif; 2011; 32(2):139-42. PubMed ID: 21654166
[TBL] [Abstract][Full Text] [Related]
49. Effects of hemoperfusion with polymyxin B-immobilized fibre on serum neopterin and soluble interleukin-2 receptor concentrations in patients with septic shock.
Nakamura T; Ebihara I; Shimada N; Suzuki S; Ushiyama C; Shoji H; Koide H
J Infect; 1998 Nov; 37(3):241-7. PubMed ID: 9892527
[TBL] [Abstract][Full Text] [Related]
50. Adsorption of various antimicrobial agents to endotoxin removal polymyxin-B immobilized fiber (Toraymyxin®).
Shimokawa K; Takakuwa R; Taya K; Wada Y; Yamazaki N; Murata M; Hirata K; Masuno T; Yokota H; Ishii F
Colloids Surf B Biointerfaces; 2012 Feb; 90():58-61. PubMed ID: 22024401
[TBL] [Abstract][Full Text] [Related]
51. Hemoperfusion with an immobilized polymyxin B fiber column reduces circulating interleukin-8 concentrations.
Kushi H; Miki T; Nakahara J; Okamoto K; Kawahara Y; Saito T; Tanjoh K
Ther Apher Dial; 2006 Oct; 10(5):425-9. PubMed ID: 17096697
[TBL] [Abstract][Full Text] [Related]
52. Removal of cytokine inducing substances by polymyxin-B immobilized polystyrene-derivative fibers during in vitro hemoperfusion of 10% human plasma containing Staphylococcus aureus challenge.
Jaber BL; Barrett TW; Cendoroglo Neto M; Sundaram S; King AJ; Pereira BJ
ASAIO J; 1998; 44(1):48-53. PubMed ID: 9466501
[TBL] [Abstract][Full Text] [Related]
53. Polymyxin B immobilized column is effective for hydrochloric acid-induced lung injury in rats.
Tsushima K; Koizumi T; Yoshikawa S; Obata T; Kubo K
Eur J Pharmacol; 2006 Mar; 535(1-3):270-9. PubMed ID: 16545795
[TBL] [Abstract][Full Text] [Related]
54. Selection of hemoperfusion therapy for patients with septic shock on the basis of the primary disease.
Kanno Y; Nemoto H; Nakamoto H; Okada H; Sugahara S; Nishidome K; Yamashita Y; Suzuki H
J Artif Organs; 2003; 6(3):205-10. PubMed ID: 14598105
[TBL] [Abstract][Full Text] [Related]
55. Effect of polymyxin B-immobilized fiber hemoperfusion on serum high mobility group box-1 protein levels and oxidative stress in patients with acute respiratory distress syndrome.
Nakamura T; Fujiwara N; Sato E; Kawagoe Y; Ueda Y; Yamada S; Koide H
ASAIO J; 2009; 55(4):395-9. PubMed ID: 19506468
[TBL] [Abstract][Full Text] [Related]
56. Toxic shock syndrome caused by hospital-acquired methicillin-resistant Staphylococcus aureus in a patient with pancytopenia.
Varghese B; Sanghavi R; Aziz A; Gosbell IB
Crit Care Resusc; 2010 Mar; 12(1):50-2. PubMed ID: 20196714
[TBL] [Abstract][Full Text] [Related]
57. Changes in serum S100A12 and sRAGE associated with improvement of the PaO(2)/FiO(2) ratio following PMX-DHP therapy for postoperative septic shock.
Takahashi G; Hoshikawa K; Matsumoto N; Shozushima T; Onodera C; Kan S; Akitomi S; Kikkawa T; Tomisawa Y; Kojika M; Sato N; Inoue Y; Suzuki K; Wakabayashi G; Endo S
Eur Surg Res; 2011; 47(3):135-40. PubMed ID: 21921634
[TBL] [Abstract][Full Text] [Related]
58. Apheresis of activated leukocytes with an immobilized polymyxin B filter in patients with septic shock.
Kumagai T; Takeyama N; Yabuki T; Harada M; Miki Y; Kanou H; Inoue S; Nakagawa T; Noguchi H
Shock; 2010 Nov; 34(5):461-6. PubMed ID: 20386499
[TBL] [Abstract][Full Text] [Related]
59. Hemoperfusion with an immobilized polymyxin B fiber column improves tissue oxygen metabolism.
Kushi H; Miki T; Nakahara J; Okamoto K; Kawahara Y; Saito T; Tanjoh K
Ther Apher Dial; 2006 Oct; 10(5):430-5. PubMed ID: 17096698
[TBL] [Abstract][Full Text] [Related]
60. [Toxic shock syndrome developed after scalding with water].
Skov LØ; Khatry S
Ugeskr Laeger; 2012 Sep; 174(36):2083-4. PubMed ID: 22944329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
